AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Collection of Blood for Multiple Collaborative Studies

Recruiting

Conditions: HIV

First Posted Date: 2011-04-18

Last Posted Date: 2025-04-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 2000

Registration Number: NCT01336855

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk

Completed

Conditions: HIV Infection
Inflammation
Cardiovascular Disease

First Posted Date: 2011-04-12

Last Posted Date: 2015-06-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 270

Registration Number: NCT01333644

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Effect of Tool Design on Hand Pain in Dental Practitioners

Not Applicable

Completed

Conditions: Shoulder Pain

Interventions: Other: narrow diameter heavy dental tool
Other: large diameter light weight tool

First Posted Date: 2011-04-11

Last Posted Date: 2012-02-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 110

Registration Number: NCT01332760

Locations: 🇺🇸
UCSF Ergonomics Program, Richmond, California, United States

Heart Rate Variability (HRV) to Evaluate Surgical Risk on Patients on Beta Blockers

Not Applicable

Withdrawn

Conditions: Cardiac Event Risk

Interventions: Drug: metoprolol

First Posted Date: 2011-04-07

Last Posted Date: 2012-06-27

Lead Sponsor: University of California, San Francisco

Registration Number: NCT01330654

Locations: 🇺🇸
Community Regional Medical Center, Fresno, California, United States

Effect of Early Limited Formula on Total Serum Bilirubin Among Newborns With Hyperbilirubinemia

Not Applicable

Withdrawn

Conditions: Hyperbilirubinemia, Neonatal

Interventions: Dietary Supplement: Nutramigen Infant Formula

First Posted Date: 2011-04-07

Last Posted Date: 2018-11-15

Lead Sponsor: University of California, San Francisco

Registration Number: NCT01330667

Locations: 🇺🇸
University of California, San Francisco Medical Center, San Francisco, California, United States

Early Aggressive Pain Management is Associated With Improved Outcomes in Blunt Thoracic Trauma

Terminated

Conditions: Rib Fracture
Sternal Fracture
Thoracic Injury

First Posted Date: 2011-04-01

Last Posted Date: 2015-04-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 43

Registration Number: NCT01327287

Locations: 🇺🇸
University of California, San Francisco at San Francisco General Hospital, San Francisco, California, United States

Early Aggressive Correction of Severe Acidosis With Tris-hydroxymethylaminomethane (THAM)

Terminated

Conditions: Resuscitation, Trauma Patients

First Posted Date: 2011-03-30

Last Posted Date: 2020-02-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT01326260

Locations: 🇺🇸
University of California, San Francisco at San Francisco General Hospital, San Francisco, California, United States

Sonographic Assessment and Visualization of Ectopics in Emergency Medicine

Completed

Conditions: Ectopic Pregnancy

Interventions: Device: Pelvic Ultrasound

First Posted Date: 2011-03-25

Last Posted Date: 2014-01-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 600

Registration Number: NCT01322958

Locations: 🇺🇸
University of California, San Francisco, California, United States

Sleep Disruption in New Mothers: An Intervention Trial

Not Applicable

Completed

Conditions: Pregnancy
Postpartum Period
Sleep Disturbance

Interventions: Behavioral: Dietary information
Behavioral: Sleep hygiene
Drug: Acetaminophen

First Posted Date: 2011-03-23

Last Posted Date: 2012-02-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 152

Registration Number: NCT01321710

Locations: 🇺🇸
University of California, San Francisco, California, United States

Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation

Completed

Conditions: Hematologic Malignancies
Fanconi Anemia
Nonmalignant Diseases
Immunodeficiencies
Genetic Inborn Errors of Metabolism
Hemoglobinopathies
Thalassemia
Sickle Cell Disease

Interventions: Drug: Fludarabine

First Posted Date: 2011-03-16

Last Posted Date: 2021-10-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 67

Registration Number: NCT01316549

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Home Terms & Conditions Privacy Policy